Soiken Holdings (TSE:2385) Research & Development: 円0 Mil (TTM As of Dec. 2025)


TSE:2385 Soiken Holdings Inc TSE:2385
56 GF Score
Price 円209.00
GF Value 円114.55
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Soiken Holdings Research & Development?

Soiken Holdings TSE:2385 +1.46% 56 Research & Development is 円0 Mil as of Dec. 2025. GuruFocus rates TSE:2385 with a GF Score™ of 56/100 and a GF Value™ of 円114.55 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Soiken Holdings's Research & Development for the three months ended in Dec. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was 円0 Mil.

Soiken Holdings  (TSE:2385) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Soiken Holdings Research & Development Related Terms

Soiken Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Soiken Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Soiken Holdings Research & Development Chart

Soiken Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Soiken Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:2385
56GF Score
Soiken Holdings Inc TSE:2385
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Soiken Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Soiken Holdings (TSE:2385) has a Research & Development of 円0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Soiken Holdings and its competitors.
Is Soiken Holdings' Research & Development too high?
Soiken Holdings' current Research & Development is 円0 Mil. Overall, Soiken Holdings has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soiken Holdings' Research & Development compare to VRTX and REGN?
Soiken Holdings' Research & Development of 円0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Soiken Holdings and its competitors. Soiken Holdings's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soiken Holdings stock overvalued right now?
Based on GuruFocus' analysis, Soiken Holdings (TSE:2385) is currently considered Significantly Overvalued. The stock's GF Value™ is 円114.55, compared to a current price of 円209.00 — trading 82.5% above its estimated fair value. The current Research & Development is 円0 Mil. Soiken Holdings' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Soiken Holdings (TSE:2385), the current Research & Development is 円0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Soiken Holdings (TSE:2385) Overvalued in 2026?

Based on GuruFocus' analysis, Soiken Holdings stock appears to be overvalued. The current stock price of 円209.00 is trading 82.5% above its estimated GF Value™ of 円114.55. GuruFocus considers Soiken Holdings to be Significantly Overvalued.

Key valuation signals for TSE:2385:

  • Research & Development: 円0 Mil
  • GF Value™: 円114.55 vs. price of 円209.00 (82.5% above fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the TSE:2385 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Soiken Holdings Business Description

Address 1-4-2 Shinsenri-Higashimachi, 13th Floor, Senri Life Science Center, Toyonaka, Osaka, JPN, 560-0082
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.
56GF Score

Get the complete analysis for TSE:2385

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円209.00
Price
円114.55
GF Value